✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

BioCryst Pharmaceuticals, Inc.

Common Name
BioCryst Pharmaceuticals
Country
United States
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
435
Ticker
BCRX
Exchange
Nasdaq
Description
BioCryst Pharmaceuticals, Inc. is a biotechnology company focused on developing and commercializing medicines for rare diseases, with a primary emphasis on hereditary angioedema (HAE). Its commercial ...

Disclosures of BioCryst Pharmaceuticals

Explore BioCryst Pharmaceuticals's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from BioCryst Pharmaceuticals's official channels and fully traceable to its official company sources.

The table below lists all of BioCryst Pharmaceuticals's' corporate disclosure by name and reporting period, ensuring full transparency and easy access.

Fiscal Year / TypeLanguages
20252 disclosures
10-K
en
DEF 14A
en
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?